Prescription Medication Drug Spending
Presentation-Password Protected-PLEASE NOTE ignore the opening comments as these relate to the live webinar, of which this is a recorded version. Allow time for the presentation to buffer and download. Also you will sign in differently with this activity, Password only!
In this knowledge-based continuing pharmacy education activity Dr C. Michael White, PharmD, FCCP, FCP, discusses current spending on prescribed medications, the cause of the increases and ways to contain healthcare expenses.
Pharmacists who are interested in the cost of healthcare and ways to contain it.
This activity is not accredited for technicians.
At the conclusion of the activity, pharmacists will be able to:
- Identify current trends in drug spending.
- Select the main drivers of high drug cost.
- Discuss the benefits and risks associated with different strategies used or proposed to control healthcare costs.
C. Michael White, Pharm.D., FCCP, FCP,
Professor and Department Head Pharmacy Practice
University of Connecticut School of Pharmacy and Director HOPES Research Group
In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.
C. Michael White, PharmD, FCCP, FCP has no actual or potential conflicts of interest associated with this presentation.
Click on the registration link to register for this activity. The cost is $15.00.
This activity has no funding.
The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1 contact hour (0.1 CEU) will be awarded to pharmacists who submit the assessment successfully with a passing grade of 70% and complete the evaluation. (ACPE #0009-0000-16-075-H04-P). Credits will be electronically transmitted to CPE Monitor within 72 hours of completing the activity.
Initial release date: December 16, 2016
Planned expiration date: December 16, 2019